📰 Thomas Plitz News

Page 2 - Thomas Plitz News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Thomas Plitz. Real-time updates on events, politics, business and more.

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS Holding SA

May 6, 2022

Relief Therapeutics Holding SA / Key word(s): AGMEGM Relief Therapeutics Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS Holding SA 06-May-2022 / 07:00 CET/CEST Release of an ad

Switzerland General Paolo Galfetti Michael Miller Patrice Jean Raghuram Selvaraju Thomas Plitz

Source: finanznachrichten.de

2022-05-06 | OTCQB:RLFTF | Press Release | Relief Therapeutics Holding AG

May 6, 2022

(2022-05-06 | OTCQB:RLFTF) Relief Therapeutics Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS Holding SA

Paolo Galfetti Michael Miller Patrice Jean Raghuram Selvaraju Thomas Plitz Thomas Hua

Source: stockhouse.com

Relief Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS Holding AG

May 27, 2021

Relief Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS Holding AG EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): AGMEGM 27.05.2021 / 07:00 Geneva, Switzerland, May 27, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (" Relief" or the " Company"), a biopharmaceutical company with its lead compound RLF-100 TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today gives notice of the Annual General Meeting (AGM) of ...

New York United States Columbia University Paolo Galfetti Patricep Jean Anne Hennecke

Source: dgap.de

Relief Therapeutics Holding AG: Relief Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS Holding AG

May 27, 2021

GENEVA, SWITZERLAND / ACCESSWIRE / May 27, 2021 / RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil)